Acusphere, Inc.
Acusphere Announces Data Demonstrating Imagify Perfusion Stress Echo Predicts Presence of Coronary Artery Disease
Published in Medical Imaging Week, November 29th, 2008
Acusphere, Inc. (NASDAQ: ACUS) announced that additional analyses from its Phase 3 clinical trials of Imagify(TM) (Perflubutane Polymer Microspheres) for Injectable Suspension were presented today at the annual American Heart Association Scientific Sessions in New Orleans, Louisiana. These results build upon the thesis presented at AHA last year that Imagify Perfusion Stress Echo is an effective and well-tolerated, minimally invasive approach to evaluating chest pain patients at risk for heart attack. The new analysis ascribes incremental predictive value to the use of Imagify for detecting coronary artery disease over other current clinical risk factors.
Imagify is the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Imaging Week
Source: Medical Imaging Week (2008-11-29)
More Articles from Medical Imaging Week
- Breast Cancer Screening
DEP Releases Third Quarter Mammography Inspections - Breast Cancer Screening
Scientists at Georgetown University publish new data on breast cancer screening - Abscess
Studies from A. Kemdem and co-authors have provided new information about abscess - Abscess Therapy
Research in the area of abscess therapy reported from University of Pittsburgh, Department of Neurological Surgery - Acute Pancreatitis
Data from University of Colorado provide new insights into acute pancreatitis - Adenoma
New adenoma study results from New York Presbyterian Hospital, Department of Neurological Surgery described - More from this issue of Medical Imaging Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
